ASPI

NASD ASP Isotopes, Inc.
Oct 3, 2026 · 9:26 AM ET EOD Market Closed

$2.91 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.91, $0.01 below the day’s high of $2.93

YTD change
-45.61%
vs 20-day SMA
-9.98%
vs 200-day SMA
-44.68%

Price ranges

Previous day
$2.75 $2.93
open $2.90 close $2.91
+$0.01 (+0.34%)
Today
$2.75 $2.93
$2.91
Past week
$2.51 $3.02
from $2.95 now $2.91
-$0.04 (-1.36%)
Past month
$2.51 $4.41
from $3.93 now $2.91
-$1.02 (-25.95%)
This year
$2.51 $8.60
from $5.35 now $2.91
-$2.44 (-45.61%)

Price & Performance

-1.30 (-30.88%) / 6M

$2.14$4.36$6.57$8.79Apr 6Jul 6Oct 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 79.9% away from all-time highs of $14.49
  • ASPI is down 46% since the beginning of the year
  • ASPI is down 68% over the past 12 months
  • ASPI is down 26% over the past 1 month
  • 20% of all ASPI investors are betting against ASPI

ASPI reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -68.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.2737
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $352.0M
Beta 3.35

Balance sheet & scale

IncomeN/A
Revenue$30.9M
Cash$259.0M
Debt$269.5K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $446.1M

ASP Isotopes, Inc. is developing a differentiated isotope enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy. It operates through the following segments: Nuclear Fuels, Specialist Isotopes and Related Services, and Helium and LNG. The Nuclear Fuels segment engages in the research and development of technologies and methods for producing HALEU and Lithium-6 for the advanced nuclear fuels target market, including the operations of QLE. The Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods for the separation of high-value, low-volume isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Dallas, TX.

Competitor comparison

TickerCompany PriceChange
LLY Eli Lilly and Company $1,142.85 -0.61%
JNJ Johnson & Johnson $256.03 -1.02%
ABBV AbbVie, Inc. $262.82 +1.11%
MRK Merck & Co., Inc. $144.30 +0.34%
RHHVF Roche Holding Ltd $428.22 -3.25%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.